The heart is the main target organ of the parasite Trypanosoma cruzi, the causal agent of Chagas' disease, a 
Introduction

Chagas' disease remains a public health problem in Latin America, where approximately 18-20 million people are chronically infected, with ~ 100 millions still at a risk of acquiring the infection [1]. Unfortunately, there is no vaccine available to prevent this disease. The causative agent of Chagas' disease is the unicelular protozoan parasite Trypanosoma cruzi. Once the infection has established in vertebrate hosts, intracellular parasite replication occurs as amastigotes, followed by the release of trypomastigote forms that can be carried by the bloodstream to infect different organs, especially the heart (reviewed in
). [4, 5] ). In fact, the most intriguing challenge to understanding the pathophisiology of Chagas' heart disease still lies in the complex host-parasite interrelationship [6] .
The most common and serious pathology seen in Chagas' disease is a cardiomyopathy characterized by inflammatory infiltrates, necrosis, and fibrosis. Chagasic cardiomyopathy leads to sudden death, complex arrhythmias, ventricular aneurysms, heart failure, and thromboemolism. Despite the importance of the cardiac clinical form, patients infected with T. cruzi may have an asymptomatic form of the disease, named indeterminate. The factors that determine the distinct clinical outcomes, leading to a mild or to a severe form, are not completely understood (reviewed in
During the acute phase of the infection, the heart is dramatically parasitized. In order to control the parasite multiplication, cells of the monocytic lineage are highly mobilized. There is an intense migration and extravasation of monocytes from the bloodstream into heart. Monocyte differentiation leads to the formation of phagocytosing macrophages, strongly activated and involved in inhibiting parasite replication in the myocardium [7, 8] [2, [7] [8] [9] .
. The ability of monocyte-derived macrophages to process and present antigens, produce cytokines, and provide costimulatory signals demonstrates their pivotal role in initiating immune responses. The importance of these cells to the host defence has been pointed out by us and other groups during the in vivo acute T. cruzi infection in both human beings and experimental models
Through use of a rat model of Chagas' disease, we have been investigating migration, accumulation and activation of monocytic lineage cells within the heart following T. cruzi infection in a series
of in vivo studies, with special interest in characterizing the ultrastructure and function of heart inflammatory macrophages [7, 8, [10] [11] [12] [13] [8, 12] (6, 12 and 20 days) [8] . These cells are voluminous with a striking increase of surface ruflings and cytoplasmic organelles, especially the Golgi complex, a finding associated with the increased ability of cell secretion [8] . Moreover, PBM show a significant increase in size at day 12 of infection [8] [20] . However, the in vivo production of nitric oxide (NO) by PBM seems to be inhibited during the acute Chagas' disease [8] .
. Compared to macrophages from non-infected animals, inflammatory macrophages undergo profound physiological changes and exhibit a distinct and remarkable morphology, which underlie their functional activities as activated cells [7]. This review covers functional and ultrastructural aspects of the heart macrophages triggered by the acute Chagas' disease, including recent discoveries on morphologically distinct, inflammationrelated organelles, termed lipid bodies, which are actively formed in vivo within macrophages in response to T. cruzi infection. These findings are defining a broader role for lipid bodies as key markers of macrophage activation during infectious diseases and attractive targets for novel anti-inflammatory therapies [13-15].
Acute T. cruzi infection induces accentuated mobilization/migration of monocytic lineage cells into heart
Peripheral blood monocytes (PBM) recruitment is a rapid and remarkable phenomenon during the acute infection with T. cruzi. At this time, we have demonstrated, in vivo, a dramatic increase in the numbers of monocytes in the blood
Although the physiological relevance of blood monocyte heterogeneity is not completely understood, it is now becoming apparent that these cells consist of several subpopulations of cells which differ both morphologically and functionally and that can be influenced by infection (reviewed in [21, 22] [21] [22] [23] [24] . For example, a considerable increase in the number of CD14 ϩ CD16 ϩ monocytes has been described in the human blood in response to infections [22] . This monocyte subset, while still in circulation, has acquired features in common with mature tissue macrophages [25] . In mice, the CX3CR1 [26] . CCR5 is involved in directing the migration of mononuclear cells to the heart early in acute infection with T. cruzi, and activate macrophages, contributing to the control of parasite replication [26] . The accentuated mobilization of monocytes in the peripheral blood occurs in concert to a prominent influx of macrophages into the heart, target organ of the disease [7, 8, 27] .
Heart inflammatory macrophages show a distinct morphology and are actively involved in parasite phagocytosis
Macrophages are widely distributed immune system cells with essential functions in homeostasis and defence [28] . Activated macrophages exert critical activities in immunity to parasites, playing a pivotal role in the mechanism for halting the acute T. cruzi infection. Activation of macrophages by parasite antigens results in pro-inflammatory cytokine production, and consequent control of parasitemia and mortality (reviewed in [2, 29] ).
The accumulation of newly recruited macrophages in the heart is one of the main findings of the acute T. cruzi infection and it is correlated with the intense myocardium parasitism, which occurs during the early infection in both experimental models and human beings (reviewed in [4, 5] [7, 11, 12, 30, 31] . Parasitemia in Y straininfected Holtzman rats peaks on day 10 of infection ( Fig. 1B) [32, 33] .
At day 12 of infection in rats, is observed the most intense inflammatory process and parasitism in the heart compared to other points during the acute phase (Fig. 1C-G Fig. 1E and 1F ). The myocarditis is predominantly mononuclear ( Fig. 2A) (Fig.  1F, arrow) [7, 8, 11, 12] . Accordingly, TEM has confirmed the presence of a large number of typical macrophages infiltrated in the heart (Fig. 2B and C) .
The tissue damage that occurs in the heart during the acute phase has been related to the intense parasitism, which induces cell alteration and destruction. At day 12, we observed that parasitized cardiomyocytes are frequently dissociated and show degenerative signs mainly in the atria, in addition to the presence of edematous interstitial tissue [8, 12] (Fig. 2A) . By TEM, cardiomyocytes in far advanced stages of disintegration with cytoskeleton changes are seen adjacent to normal cells [10] . Other experimental models such as dogs [27] or Calomys callosus [34] show the same cardiomyocyte alterations by both light and/or electron microscopy.
We have been studying the ultrastructure of heart inflammatory macrophages in more detail during acute T. cruzi infection [7, [10] [11] [12] [13] 20] (Fig. 4B) [7] . We have measured the diameter of heart macrophages in noninfected and infected animals and inflammatory macrophages show a significant increase in size compared to macrophages from non-infected animals [12] . Morphological signs of activation in inflammatory macrophages within the heart also include a striking increase in surface projections and pseudopodia (Figs 3B and 4B) [7, 12] . Morphological characteristics of activation as above described are also present in activated macrophages during the experimental infection with Trypanosoma congolense [35] , and have been recognized as an accurate indication of high phagocytic and microbicidal activities of macrophages [7, [35] [36] [37] .
In [21, [38] [39] [40] [41] . Therefore, the nature of the stimulus, or the combination of stimuli, can exert a profound effect in terms of macrophage morphology and functional capabilities [7, 40, 42] .
TEM has also revealed a remarkable ability of heart inflammatory macrophages to establish cell-to-cell interactions, mostly macrophage-monocyte, macrophage-macrophage or macrophagelymphocyte interactions in response to the acute phase of Chagas' disease ( Fig. 3A) [7, 13] . These interactions are characterized by multiple areas of close apposition of the plasma membrane of the 2 cells or cell-to-cell attachments (Fig. 3A) , and may have relevance for macrophage and/or T-cell activation [7] .
The biology of T. cruzi-macrophage interaction has been investigated (reviewed in [43] ). Macrophages from different origins [38] including heart macrophages [44] are able to express the surface receptor sialodhesin (Sn). This receptor recognizes sialic acid, present in high amounts at the parasite surface and seems to have an important role in the adherence process during T. cruzi phagocytosis [45] . In fact, phagocytosis is the main process for parasite internalization by macrophages. In vivo, heart inflammatory macrophages are actively involved in T. cruzi phagocytosis and killing and degenerating amastigotes are frequently observed within these macrophages by TEM [7, 12] (Fig.  2B and C) . Experiments based on macrophage depletion by silica, a selective cytotoxic agent for macrophages, emphasize the importance of newly formed monocyte-derived macrophages in the resistance to the T. cruzi infection [7] . Depletion of macrophages by silica leads to a marked increase in the number of amastigote nests in the heart [7, 10] . Histoquantitative studies have demonstrated that parasite nests correspond to 16.5 Ϯ 12.5% of the myocardium in silica-treated/infected animals compared to 1.9 Ϯ 12.5% in rats only infected [7] . On the contrary, IFN-␥-treated rats show reduced heart parasitism [46] [12] . [51, 52] [39, 41] [58] [59] [60] [61] . In contrast, it has also been demonstrated that neither NO production [62] nor iNOS [63] [71] [72] [73] . Figs 3A,B and 4B) [20] . While Fig. 4A and 4B) [20] .
N, nucleus; V, blood vessel. Scale bar, 10 m (A), 2 m (B), 1 m (C).
Fig. 3 Activated heart macrophages triggered by the acute Trypanosoma cruzi infection. A clear interaction between an activated macrophage and a lymphocyte is observed in (Ai). Note areas of cell-to-cell attachments (circles). A phagolysosome is seen within the macrophage cytoplasm in close apposition to lipid bodies (LB) (box). (Aii) Higher magnification of the boxed area shows LBs with different electron densities and sizes. (Bi) Other features of macrophage activation include increase of both surface projections (arrowheads) and LB numbers and prominent Golgi complex profiles. Boxed areas show details of LBs and Golgi in higher magnification in Bii and Biii, respectively. Heart samples were processed for transmission electron microscopy at day 12 of infection. N, nucleus; My, myocardium. Scale bar, 600 nm (Ai); 400 nm (Aii); 750 nm (Bi) and 500 nm (Bii and Biii).
Fig. 4 Ultrastructural features of a control and an inflammatory macrophage in the heart following infection with Trypanosoma cruzi (12 days). (A)
are essential for the in vivo control of T. cruzi in mouse models. Of note, in our rat model of T. cruzi infection, there is no significant in vivo production of NO by both splenic and peritoneal macrophages during the acute disease, in spite of the control of the parasitemia and heart parasitism (Fabrino, unpublished data). In investigating the respiratory burst responses of macrophages from different origins to the in vivo infection in rats, we also observed that the infection increases the hydrogen peroxide (H2O2) production by splenic but not by peritoneal macrophages [12], indicating that the in vivo production of antimicrobial molecules seems related to specific types of macrophages and/or the parasite ability to activate these cells [12].
Lipid bodies as structural markers of inflammatory macrophages
A distinguishing ultrastructural feature of Chagas' disease-triggered macrophages is the presence of increased numbers of distinct cytoplasmic organelles termed lipid bodies (also known as lipid droplets) [20]. Lipid bodies are lipid-rich organelles found in small numbers in most eukaryotic cells as roughly spherical organelles (Fig. 4A), comprised of an outer monolayer of phospholipids which have a unique fatty acid composition, a core containing neutral lipids such as triglycerides and cholesterol, and variable protein composition. In the past, lipid bodies were largely associated with lipid storage, but it has become apparent that lipid bodies are dynamic and functionally active organelles [13, 64-67]. It is well documented that upon cell activation during different conditions, a significant increase of the LB numbers occurs in the cytoplasm, especially in activated leukocytes (reviewed in [15, 68, 69]). These organelles have been recognized as cytoplasmic domains for synthesis of inflammatory mediators (eicosanoids) in leukocytes from natural and experimental inflammatory processes such hypereosinophilic syndrome, acute respiratory distress syndrome and Crohn's disease (reviewed in [15, 70]). Several eicosanoid-forming enzymes pertinent to arachidonate mobilization and oxidative metabolism including lipoxygenases and cyclooxygenases are associated intracellularly with lipid bodies
Lipid body formation was identified by us in both peritoneal and heart macrophages during different times of acute T. cruzi
Fig. 5 Activation of heart inflammatory macrophages during the acute infection with Trypanosoma cruzi. In response to acute infection, a cascade of events recruit cells derived from monocytic lineage from the peripheral blood into heart. This cascade culminates in a strong activation of macrophages. Classical activation of macrophages involves the key cytokine interferon gamma (INF-␥) and T. cruzi components (GPI anchors and CpG-rich DNA). These parasite products are recognized at the macrophage surface by Toll-like receptors (TLRs), a class of pattern recognition receptors (PRRs), which initiate an immune response and directly activate macrophages. Activated macrophages kill the parasite through various effector mechanisms such as TNF-␣ production. PAMPS, pathogen-associated molecular patterns; GPI, glycosylphosphatidylinositol; TNF-␣, tumour necrosis factor-alpha; MIP-1␣, macrophage inflammatory protein1␣; MCP-1/CCL-2, monocyte chemoattractant protein-1; IP-10, inducible protein 10. infection in vivo (
Since [64] .
We have demonstrated that in vivo lipid body formation within inflammatory macrophages is strongly associated with the host response not only during the acute infection with T. cruzi [20] but also with other pathogens such as Mycobacterium bovis bacillus Calmette-Guérin -BCG [14]. For this reason, our group has recently highlighted these distinct organelles as structural markers of the innate immune responses in phagocytic cells [13]. In contrast to inflammatory macrophages, peripheral blood monocytes from T. cruzi-infected animals show low number of lipid bodies [20]. This may be associated with the fact that these cells are not directly involved or have a minor participation in the modulation of inflammation in target tissues where the eicosainoids function as paracrine mediators. On the other hand, the maturation of peripheral blood monocytes to tissue macrophages followed by activation of these cells is likely involved in lipid body
formation and eicosanoid release [20] . [13, 14, 20] Fig. 4A and B) . Of note, lipid bodies change consistently their osmiophilia in macrophages stimulated in vivo with higher parasite load in irradiated-infected rats (Fig. 6B) (Fig. 4B) [67] .
One intriguing aspect of lipid bodies is their osmiophilia, which is dependent on the cell type and can change during elicited inflammatory responses (reviewed in [15]). In inflammatory macrophages, the lipid body density can consistently change during pathogen infections, as revealed by ultrastructural studies
. Based on osmiophilia, lipid bodies were recently identified and quantitated as three main types (light, electron and strongly electron-dense) within inflammatory macrophages from different origins, especially from the heart [13]. T. cruzi infection induces a significant increase in the numbers of light dense lipid bodies compared to non-infected controls which show lipid bodies preferentially as electron dense structures (
[13]. Of interest, by proteomic and ultrastructural studies we have recently defined lipid bodies as organelles with internal endoplasmic reticulum (ER)-like membranes and ER luminal proteins, suggesting a model by which enveloped ER-membranes and domains form lipid bodies
Another morphological feature of lipid bodies is their considerable size variation (Fig. 6A and B) . (Fig. 6A) [13] . These findings reveal that not only the number, but also the osmiophilia and size of lipid bodies represent structural indicatives of the participation of these organelles in innate immune responses [13, 74] .
There has been increasing evidence that formation of lipid bodies in the course of infections involves well-regulated mechanisms and may have implications for microbial pathogenesis. However, the detailed molecular mechanisms controlling inducible lipid body biogenic process within leukocytes remain to be defined (reviewed in [15]). In both migrating neutrophils and macrophages, in vivo stimulation with pathogen-related molecules (lipopolysaccharide and lipoarabinomannan), bacterial sepsis or BCG causes lipid body biogenesis through direct activation of CD14, TLR2 and TLR4 [14, 75, 76]. Indirect activation by endogenous mediators, like platelet activating factor (PAF), also contributes to lipid body biogenesis during infected-driven inflammation [75]. Both Mycobacterium bovis BCG [14] and T. cruzi (D'Avila, unpublished data) induce lipid body formation in a TLR-2-dependent pathway, but TLR4 seem not to be involved in this mechanism [14]. Moreover, it was recently demonstrated that MCP-1 acts as a key endogenous mediator for rapid biogenesis of Leukotriene B4-synthesizing lipid bodies within macrophages in infection-driven inflammatory disorders (sepsis or endotoxemia).
The MCP-1-elicited lipid body formation was dependent on activation of a CCR2-elicited ERK and P13K signalling [77] .
One important aspect of newly formed lipid bodies in inflammatory macrophages from animals infected with T. cruzi or BCG is phagolysosomes. A close association between an LB and a phagolysosome is indicated by arrows in (Bii). (Bii) corresponds to the boxed area in (Bi). Arrowheads point to small LBs. Amastigotes (*) are also observed in the cytoplasm. (C) LBs are seen within or in contact (arrow) to phagolysosomes containing degenerating material. N, nucleus; My, myocardium. Before infection, rats were irradiated or not and heart samples processed at day 12 of infection [13]. Scale bar, 1.25 m (Bi); 700 nm (Bii); 600 nm (C). Reprinted from ref. [13] with permission.
their ability to interact with phagolysosomes and to relocate in the cytoplasm suggesting an association between these structures (Figs 3A, 4B and 6B) [14, 20] . Quantitative TEM revealed that 47% of lipid bodies were associated with phagolysosomes within Chagas' disease-elicited inflammatory macrophages, in addition to be noted within phagolysosomes (Fig. 6C) [13] . Similar association between lipid bodies and latex bead-containing phagosomes has been confirmed by high-resolution Raman microscopy in neutrophilic granulocytes [78] . The clear association lipid bodyphagosome points to a yet ill-understood role of lipid bodies in pathogen control. It has been demonstrated that arachidonic acid has important functions in the induction of apoptosis of mycobacterium-infected macrophages, and in actin recruitment to the phagosome, enabling phagosome maturation and increased mycobacterial killing [79, 80] . The lipid body-phagosome association as well as the internalization of lipid bodies by phagosomes during the acute T. cruzi infection may, therefore, represent different stages of phagosome maturation leading to killing of the parasite [74] .
Of interest, we [67] and other groups [81] [82] [83] [84] 
Macrophages and the resolution of acute inflammation and heart repair
Histopathological analyses of both atria and ventricles show an apparent inflammation resolution in concert to myocardium repair at the end of the acute phase of T. cruzi infection (Fig. 1G) [8] . Are macrophages involved in these phenomena? In fact, macrophages are recognized for taking part in the resolution of acute inflammation and in wound healing in a range of diseases and injuries [93] [94] [95] [96] [97] . The macrophage plasticity is particularly relevant to the resolution of inflammation. These cells can respond to a variety of stimuli and undergo distinct physiological changes. If the environment in which the macrophage resides changes, so too will the functional properties of these cells change [51] . Therefore, components present in the local microenvironment can prime macrophages to adopt unique phenotype to promote resolution of inflammation, i.e. macrophages that had previously been the major contributor to the inflammatory process can later participate in its resolution through the production of cytokines, growth factors and angiogenic factores [51] .
Although the participation of macrophages in the inflammation resolution and subsequent tissue repair at the end of the acute Chagas' disease remain to be defined, the large number of activated macrophages present in the myocardium may likely play a role in these processes. At day 20 of T. cruzi infection in rat models, both parasitism and inflammation (Fig. 1C and G) are dramatically decreased in the heart in parallel to a drop of monocyte numbers in the blood (Fig. 1A) [8] (Fig. 1G) , indicating that myocardium repair is a rapid and consistent phenomenon by the end of the acute Chagasic infection [8] . Indeed, it is becoming apparent that the heart responds to T. cruzi infection with DNA repair and cell multiplication in the inflamed sites and with hypertrophy of the unaffected myocardium [98] . Of note, skeletal muscle regeneration is also documented following infection with T. cruzi [99] .
In a different perspective though, the excessive activation of innate immunity, leading to an uncontrolled inflammatory cytokine production by macrophages, can result in a variety of pathological processes and autoimmune diseases (reviewed in [51, 55] ). In fact, the immune response against T. cruzi has been hypothesized to contribute to the acute cardiac damage [27] , but the occurrence of autoimmunity during Chagas' disease in both acute and chronic phases is still a matter of debate (reviewed in [5, 100, 101] 99, 100] .
The restoration of the inflamed myocardium to its prior physiological functioning, however, does not eliminate completely the parasite nor prevent the development of a progressive chronic symptomatic phase, characterized by irreversible pathological changes in the heart, the chronic Chagas' heart disease, observed in 30-40% of infected individuals (reviewed in [5] ). Chagasic cardiomyopathy is a major life-threatening complication of T. cruzi infection in human beings [5] . This cardiomyopathy has been associated with the host immune response. On the other hand, the parasite is becoming increasingly detected in chronically infected hosts and may also be the cause of pathology either directly or through parasite-specific mediated inflammatory responses (reviewed in [5, 101] ). The parasite persistence hypothesis supports research into immune enhancing therapies, including vaccine development with the primary goal of reducing the parasite load [102] .
Concluding remarks
Chagas' disease remains a prominent problem with a major impact on public health in Latin America. The outcome of this protozoan infection, which highly affects the heart, is crucially dependent on activation events of the monocyte/macrophage system. Newly recruited monocyte-derived macrophages are actively involved in parasite phagocytosis in the heart and exhibit varying degrees of morphological heterogeneity and mixed activation states [7, 8] 
